MXCT
Price:
$1.12
Market Cap:
$119.98M
MaxCyte, Inc. is a global life sciences enterprise focused on the innovation, advancement, and commercialization of next-generation cell therapies. The company offers a suite of advanced electroporation systems, including the ExPERT ATx, a static device for small to medium-scale cell transfection; the ExPERT STx, which uses flow electroporation to support protein production, drug development, and the expression of therapeutic targets for cell-based assays; the ExPERT GTx, another flow electroporation solution designed for large-scale transfection in therapeutic applications; and the ExPERT VLx, catering to very high-volume cell engineering needs. Additionally, MaxCyte provides disposable pro...[Read more]
Industry
Medical - Devices
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
MXCT
According to MaxCyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 122.91M. This represents a change of -24.28% compared to the average of 162.32M of the last 4 quarters.
The mean historical Enterprise Value of MaxCyte, Inc. over the last ten years is 684.18M. The current 122.91M Enterprise Value has changed 1.70% with respect to the historical average. Over the past ten years (40 quarters), MXCT's Enterprise Value was at its highest in in the June 2021 quarter at 1.40B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.
Average
684.18M
Median
684.83M
Minimum
162.84M
Maximum
1.17B
Discovering the peaks and valleys of MaxCyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.26%
Maximum Annual Enterprise Value = 1.17B
Minimum Annual Increase = -61.80%
Minimum Annual Enterprise Value = 162.84M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 162.84M | -61.80% |
| 2024 | 426.32M | -6.84% |
| 2023 | 457.60M | -18.33% |
| 2022 | 560.33M | -36.42% |
| 2021 | 881.31M | -24.62% |
| 2020 | 1.17B | 22.97% |
| 2019 | 950.76M | 10.05% |
| 2018 | 863.91M | 7.10% |
| 2017 | 806.62M | 43.26% |
| 2016 | 563.05M | -24.08% |
The current Enterprise Value of MaxCyte, Inc. (MXCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
348.92M
5-year avg
497.68M
10-year avg
684.18M
MaxCyte, Inc.’s Enterprise Value is less than Profound Medical Corp. (157.89M), greater than TriSalus Life Sciences, Inc. (120.86M), greater than Anteris Technologies Global Corp. (57.14M), greater than LENSAR, Inc. (60.53M), greater than Owlet, Inc. (61.90M), less than Perspective Therapeutics, Inc. (176.54M), less than Prenetics Global Limited (312.16M), less than Armata Pharmaceuticals, Inc. (647.19M), greater than Nano-X Imaging Ltd. (81.18M), greater than Sangamo Therapeutics, Inc. (53.89M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 157.89M | $200.47M | |
| 120.86M | $142.92M | |
| 57.14M | $336.61M | |
| 60.53M | $70.45M | |
| 61.90M | $84.14M | |
| 176.54M | $227.89M | |
| 312.16M | $367.72M | |
| 647.19M | $278.27M | |
| 81.18M | $122.48M | |
| 53.89M | $62.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MaxCyte, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MaxCyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is MaxCyte, Inc.'s Enterprise Value?
What is the highest Enterprise Value for MaxCyte, Inc. (MXCT)?
What is the 3-year average Enterprise Value for MaxCyte, Inc. (MXCT)?
What is the 5-year average Enterprise Value for MaxCyte, Inc. (MXCT)?
How does the current Enterprise Value for MaxCyte, Inc. (MXCT) compare to its historical average?